Klaviyo, Inc.

For the period ended Mar 31, 2026. Filed May 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

KVYO$20.43-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets (Unaudited)

	As of,
	March 31, 2026	December 31, 2025
Assets
Current assets:
Cash and cash equivalents	$984,590	$1,064,875
Restricted cash	738	738
Accounts receivable, net of allowance for doubtful accounts	72,302	60,714
Deferred contract acquisition costs, current	33,588	29,634
Prepaid expenses and other current assets	55,273	50,115
Total current assets	1,146,491	1,206,076
Property and equipment, net	84,458	80,341
Right-of-use assets, net	96,135	101,126
Deferred contract acquisition costs, non-current	55,229	47,769
Prepaid marketing expense	127,724	132,849
Other non-current assets	13,580	12,443
Total assets	$1,523,617	$1,580,604
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$21,613	$29,072
Accrued expenses	113,971	125,159
Lease liabilities, current	23,969	24,757
Deferred revenue	111,493	103,245
Total current liabilities	271,046	282,233
Lease liabilities, non-current	93,238	95,991
Other non-current liabilities	5,874	5,820
Total liabilities	370,158	384,044
Stockholders’ Equity
Preferred stock: $0.001 par value; 100,000,000 shares authorized; 0 and 0 shares issued and outstanding at March 31, 2026, and December 31, 2025, respectively.	—	—
Series A common stock: $0.001 par value; 3,000,000,000 shares authorized; 148,389,736 and 144,262,443 shares issued at March 31, 2026, and December 31, 2025, respectively; 144,081,867 and 144,262,443 outstanding at March 31, 2026, and December 31, 2025, respectively.	144	144
Series B common stock: $0.001 par value; 350,000,000 shares authorized; 158,456,935 and 159,899,668 shares issued and outstanding at March 31, 2026, and December 31, 2025, respectively.	158	160
Treasury stock: $0.001 par value; 4,307,869 and 0 shares held at March 31, 2026 and December 31, 2025, respectively	4	—
Additional paid-in capital	2,021,068	2,073,209
Accumulated deficit	(867,915)	(876,953)
Total stockholders’ equity	1,153,459	1,196,560
Total liabilities and stockholders’ equity	$1,523,617	$1,580,604

The accompanying notes are an integral part of these condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.